Header
Sir Ganga Ram Hospital, New Delhi

Cancer Remission: Meaning, Cure and Follow-Up

Summary

Cancer remission means tests can no longer find your cancer (complete remission), or the cancer has shrunk and is under control (partial remission). It isn't the same as a cure, because a few cancer cells can remain undetected and may cause the cancer to return months or years later. That's why follow-up care matters.

Visits are usually closest together in the first two to three years, when recurrence is most likely, and then spread out, with many people continuing yearly check-ups after five years. Your own schedule and risk depend on your cancer type, stage, and treatment, so your oncologist is the best source for both.

Cancer Remission: What It Means and How Follow-Up Works

The difference between remission and cure, how likely recurrence is, and what the years after treatment look like

Summary

Cancer remission means tests can no longer find your cancer (complete remission), or the cancer has shrunk and is under control (partial remission). It isn’t the same as a cure, because a few cancer cells can remain undetected and may cause the cancer to return months or years later. That’s why follow-up care matters. Visits are usually closest together in the first two to three years, when recurrence is most likely, and then spread out, with many people continuing yearly check-ups after five years. Your own schedule and risk depend on your cancer type, stage, and treatment, so your oncologist is the best source for both.

This page is for informational purposes only and does not replace medical advice. Please consult Dr Aditya Sarin or a qualified oncologist about your own results and follow-up schedule. As of 2026, this reflects current clinical guidance.

Hearing the word “remission” can feel like both a finish line and a question mark. It’s good news, and it’s also incomplete news. Here’s what the term actually means, how it differs from a cure, how recurrence risk works, and what follow-up care usually involves.

What does remission mean in cancer?

Remission means your cancer is responding to treatment or is under control. The American Cancer Society describes it as the period when cancer is responding to treatment or under control, and notes that many people assume it means cured when it may not.

Complete remission

In complete remission, all signs of cancer have gone, and no test can find cancer cells. Doctors also describe this as “no evidence of disease,” or NED. One oncologist’s plain-language guide describes NED as a snapshot of what scans, blood work, and exams show today, while remission refers to a stretch of time. Both are good news, but neither guarantees a cure.

Partial remission

In partial remission, the cancer has shrunk but hasn’t completely gone. The exact threshold varies by source and cancer type. Breastcancer.org says tumours must be at least 50% smaller or have stopped growing, while treatment-response criteria used in clinics often cite about 30% shrinkage. If your report uses these terms, ask your oncologist which definition applies to you.

Is remission the same as cure?

No. According to the ACS, cure means no traces of cancer remain after treatment, and it isn’t expected to come back. But even when tests show nothing, a few cancer cells may remain, and they can cause the cancer to return weeks, months, or years later.

What about “cancer-free after five years”?

Some oncologists say a person is cancer-free, or effectively cured, after five years in complete remission. Not all doctors agree. Breastcancer.org notes that some find the definition misleading, since certain cancers, breast cancer among them, can recur after five years. This is why doctors tend to say “remission” rather than “cured,” and it’s not a sign of pessimism about your case.

Can cancer come back after remission?

Yes, and it’s called recurrence. It can happen any time after treatment ends. The National Cancer Institute’s booklet on recurrence explains that recurrent cancer starts from cells that the first treatment didn’t fully remove or destroy, sometimes too small to see on follow-up tests. That doesn’t mean your treatment was wrong, and it’s not your fault.

Types of recurrence

  • Local: the cancer returns in the same place as before
  • Regional: it returns in nearby lymph nodes or tissues
  • Distant: it appears in another part of the body, also called metastasis

Recurrent cancer keeps its original name. As Cedars-Sinai explains, breast cancer that returns in the bones is treated as breast cancer, not bone cancer.

What is my risk of recurrence?

There’s no sure way to know. The Cedars-Sinai guide says your risk depends on the type of cancer, your overall health and age, the treatments used, and other factors, and that doctors can’t say for certain whether your cancer will return.

Some general patterns do exist. Recurrence is generally most likely in the first few years after treatment. For cervical cancer, one clinic notes most recurrences happen within two to three years, with late recurrences past five years uncommon but possible (Thomson Medical). For breast cancer, a medically reviewed summary says the risk declines each year steadily for about ten years and then levels off. Because patterns differ by cancer, your oncologist is the best source for your own risk, as they can factor in your stage, receptor status, and treatment. For breast cancer specifically, see our breast cancer treatment guide.

How long is follow-up after cancer treatment?

Follow-up is front-loaded. Visits are closest together when recurrence is most likely, then they spread out. Here are examples of typical schedules, which vary by cancer and by guideline:

Cancer

Typical follow-up pattern

Lung

Every 3 months for 2 years, every 6 months for the next few years, then at least yearly after 5 years (Medical News Today, citing ACS)

Breast

Exam every 3 to 6 months for about 3 years, every 6 to 12 months for the next 2 years, then yearly (MyBCTeam)

Ovarian

Every 2 to 4 months for 2 years, every 3 to 6 months in years 3 to 5, then yearly (CION, citing NCCN and ESMO-ESGO)

Treat these as illustrations, not your personal plan. Ask your oncologist for your own timetable.

What happens at a follow-up visit?

Your team will ask how you’re feeling and examine you. Depending on your cancer, they may order blood tests and imaging such as ultrasound, CT, or MRI. 

More scans aren’t always better

Many guidelines limit routine imaging unless there’s a reason. For endometrial cancer, for example, a Brazilian guideline summary says imaging is generally reserved for advanced disease or clinical suspicion, and that the CA-125 blood marker isn’t recommended for routine use. If you’re offered a PET-CT or a package of tumour marker tests with no clear reason, it’s fair to ask what question the test is meant to answer.

What is a survivorship care plan?

It’s a written summary to ask for when treatment ends. It can include a schedule of follow-up tests and exams, a list of possible long-term or delayed side effects, and suggestions for staying healthy and lowering recurrence risk (Medical News Today). Many hospitals don’t offer one automatically, so it’s worth asking for it.

What symptoms should I report between visits?

Tell your team if any symptom you had before the cancer returns, or if something new lasts more than a couple of weeks. Cedars-Sinai points out that new symptoms may be late side effects of treatment, or may have nothing to do with cancer at all, like infections and aches. The only way to know is to get checked. 

What if cancer comes back?

A recurrence is hard news, and it’s normal to feel fear, anger, or grief. Treatment depends on the cancer type, where it’s growing, what you had before, how long it’s been since treatment, and your overall health and preferences. For breast cancer, the National Cancer Institute says another round of treatment may control or shrink a local or regional recurrence, and distant recurrences are harder to treat but still have many options. The plan may match your first treatment or be completely different, so it makes sense to revisit your options, including getting a second opinion.

Practical follow-up tips in India

  • Keep a folder with your pathology report, scan discs, treatment summary, and a list of drugs and doses.
  • Book your next visit before you leave, and reschedule quickly if you have to miss one.
  • Ask who to call if something worrying comes up between appointments.
  • Plan for travel and costs. If you live far from your treating centre, ask whether some visits can be done locally with your reports shared.

The takeaway

Remission is good news that deserves to be celebrated, and it’s also a stage that needs ongoing attention. Understanding the difference between remission and cure, knowing what follow-up looks like, and keeping your appointments gives you the best chance of catching any problem early and calmly. If you’re finishing treatment and want a clear plan for what comes next, book a consultation with Dr Aditya Sarin.

References

Frequently Asked Questions

What does complete remission mean?

It means all signs of cancer have disappeared on exams, scans, and lab tests. It’s often called no evidence of disease (NED), but a few cancer cells may remain undetected, so follow-up continues.

What is the difference between remission and cure?

Remission means the cancer is undetectable or under control for now. Cure means it’s gone and not expected to return. Doctors usually say remission because they can’t promise it won’t come back.

How long does remission last?

It varies widely. Some people stay in remission for life, and some experience recurrence. Your cancer type, stage, and treatment all affect it.

What is the chance of cancer coming back?

It depends on the cancer type, stage, treatment, and your overall health. Your oncologist is the best person to estimate your personal risk.

How often do I need check-ups after cancer treatment?

Often every few months for the first two to three years, then every 6 to 12 months up to five years, then yearly. Your schedule may differ.

Does remission mean I can stop treatment?

Not always. Some people continue hormone therapy or other maintenance treatment during remission. Follow your oncologist’s advice.

Is being cancer-free after five years the same as cured?

Not necessarily. Five years is a common milestone, but some cancers can return later, and many doctors avoid using the word “cured.”

Dr. Aditya Sarin — Medical Oncologist, Sir Ganga Ram Hospital, Delhi
Medically reviewed & written by

Dr. Aditya Sarin

Consultant, Medical Oncology · Sir Ganga Ram Hospital, New Delhi

MD (General Medicine) · DrNB (Medical Oncology) · ESMO (European) Board Certified

Dr. Aditya Sarin is a medical oncologist who combines precision molecular profiling with evidence-based, compassionate cancer care. Named Young Medical Oncologist of the Year, he treats the full spectrum of solid and blood cancers through a multidisciplinary tumor-board approach at Sir Ganga Ram Hospital.

Breast Cancer Lung Cancer GI Cancers Head & Neck Gynecologic Cancers Immunotherapy Targeted Therapy Precision / Molecular Oncology Leukemia · Lymphoma · Myeloma

Cancer Diagnosis in India: Tests, Scans and Screening

Summary

No single test can diagnose cancer. Doctors combine your history, a physical exam, blood tests, scans (such as ultrasound, CT, MRI, and PET-CT), and almost always a biopsy, which confirms the diagnosis. After diagnosis, staging tests show how far the cancer has spread, and biomarker tests on the tumour help choose treatment.

In India, free screening for oral, breast, and cervical cancer is offered to people aged 30 and above through Ayushman Arogya Mandirs, but uptake is still low. The biggest practical lesson is to act early: a new lump, a non-healing sore, or an unexplained change lasting more than a couple of weeks deserves proper evaluation.

Cancer Diagnosis in India: Tests, Scans and What Every Patient Should Know

How cancer is diagnosed, what each scan does, which screening tests are available, and how to avoid delays

This page is for informational purposes only and does not replace medical advice. Please consult Dr Aditya Sarin or a qualified oncologist about which tests apply to you. Prices and programmes change, so confirm details with your hospital. As of 2026, this reflects current clinical guidance.

When something feels wrong, or a scan picks up something unexpected, the path to a clear answer can feel like a maze of acronyms and appointments. CT, MRI, PET-CT, FNAC, IHC. Which one is needed, in what order, and why? This guide walks through the whole diagnostic journey in plain language, with an India-specific look at screening and cost.

How is cancer diagnosed?

There’s no single test

The National Cancer Institute is clear on this: no one test diagnoses cancer. Your doctor may start with your personal and family history and a physical exam, then order lab tests, imaging, or other procedures depending on what they suspect.

The usual sequence

Every case differs, but the path often looks like this:

  1. Symptoms or a screening finding prompt a visit
  2. History and physical exam
  3. Blood and urine tests to look for abnormalities
  4. Imaging to find and measure any mass
  5. Biopsy to confirm whether it’s cancer
  6. Staging tests to see how far it has spread
  7. Biomarker and genetic tests on the tumour to guide treatment

Imaging can show the presence, location, and size of an abnormal mass, but according to the Merck Manual, it can’t confirm that cancer is the cause. That requires a tissue sample.

Blood and urine tests

Lab tests help build the picture but don’t diagnose cancer on their own. The NCI points out that abnormal results aren’t a sure sign of cancer and have to be read alongside imaging and biopsy findings.

Complete blood count

In blood cancers such as leukaemia, a routine blood count can reveal an unusual number or type of white blood cells, which is often the first clue.

Tumour markers

Tumour markers are substances made by cancer cells or by the body in response to cancer. They can help with diagnosis, treatment decisions, and tracking response. But normal cells also produce most of them, so high levels don’t mean cancer, and normal levels don’t rule it out. Tumour marker tests also aren’t routine screening tools for most people, so be cautious of “full-body cancer marker” packages sold without a medical reason.

Scans: What each one does

Different scans answer different questions. As one cancer-care guide to choosing scans puts it, the right scan answers your clinical question, and it isn’t always the most expensive.

Scan

How it works

Often used for

X-ray

Low-dose radiation images

First look at chest, bones

Ultrasound

Sound waves, no radiation

Breast, thyroid, liver, ovary, kidney, pancreas

CT scan

Many X-ray images combined into slices

Brain, lungs, abdomen, lymph nodes; staging

MRI

Magnets and radio waves, no radiation

Brain, spinal cord, bones, soft tissue

PET-CT

Radioactive sugar shows active cells, combined with CT

Staging and checking spread; lung, head and neck, breast, lymphoma

Bone scan

Radioactive tracer highlights bone changes

Checking bone spread

Organ-specific uses draw on the Merck Manual.

CT scan for cancer: What to expect

A CT scan is one of the most common tests in cancer care. You lie on a table that slides through a ring-shaped scanner, and it’s painless. Some scans use contrast dye, either swallowed or given through an IV, to make organs show up more clearly. Tell the radiologist if you’ve ever reacted to contrast dye or if you might be pregnant.

On safety, the CDC notes that CT scans use more radiation than a standard X-ray, and that added radiation exposure can slightly raise the chance of cancer later in life. A Queensland Health patient leaflet adds key context: for someone who needs a scan, the small risk is outweighed by the expected benefit. The practical takeaway is to have scans your doctor recommends, and to question scans that seem repeated without a clear reason.

PET-CT scan

A PET-CT combines two tests. A radioactive sugar collects in areas of active cells, and the CT adds detailed anatomy. It’s used to stage some cancers and check for spread, but it isn’t always needed, and it can miss some tumours, such as certain mucinous ones. For brain involvement, MRI is usually the standard test.

Biopsy and cancer pathology

A biopsy is the only way to definitively confirm most cancers. A pathologist examines the tissue and writes a report with the diagnosis, grade, and, where relevant, margins, lymph node status, and biomarkers. If the diagnosis is rare or unclear, or if the biopsy was done at a small lab, consider a second pathology review before starting treatment.

Staging: How far has it spread?

Once cancer is confirmed, staging tests describe its size, whether it has grown into nearby structures, and whether it has spread to lymph nodes or other organs. The choice of tests depends on the cancer type and may include X-rays, CT, MRI, bone scans, or PET-CT. Blood tests may also check whether the cancer is affecting the liver, bones, or kidneys.

Waiting for staging results is stressful, and many people want to start treatment immediately. But staging lets the team choose the most appropriate treatment, so the short wait is worth it.

Biomarker and genetic testing

Many cancers are also tested for biomarkers on tumour cells, such as HER2 and EGFR, that help decide whether targeted therapy or immunotherapy is likely to work. This is why a medical oncologist often links diagnosis and treatment planning.

Cancer screening tests in India

Screening looks for cancer in people with no symptoms. Diagnosis is for people who have symptoms or a suspicious finding. They’re different tools.

What the national programme offers

India’s National Programme for Prevention and Control of Non-Communicable Diseases targets people over 30 for screening for three common cancers: oral, breast, and cervical (PIB, Ministry of Health). Screening is part of the services at Ayushman Arogya Mandirs, where ASHA workers assess risk using a checklist and bring people in for screening and referral (Lok Sabha reply). For cervical cancer, women aged 30 to 65 are offered a visual inspection test (VIA) once every five years at public health facilities.

Why coverage still lags

Reach is improving, but it’s far from complete. As of July 2025, 10.18 crore of an eligible 25.42 crore women aged 30 and above had been screened for cervical cancer, per the same report. A scoping review in the Asian Pacific Journal of Cancer Prevention notes that NFHS-5 found only 1.9% of women aged 30 to 49 had ever been screened for cervical cancer, and 0.9% for breast cancer. If you’re over 30 and have never been screened, it’s worth asking at your nearest Ayushman Arogya Mandir or government health centre.

What guidelines recommend elsewhere

The American Cancer Society recommends, for average-risk adults: regular colorectal screening from age 45, yearly mammograms for women aged 45 to 54 (with the option to start at 40), and yearly low-dose CT for lung cancer in people aged 50 to 80 with a heavy smoking history. These are US-based guidelines and Indian programmes differ, so ask your doctor what suits your age, family history, and risk. 

Don’t wait on warning signs

Screening is for people who feel fine. If you notice something, don’t wait. Examples worth prompt evaluation include a new lump; a mouth ulcer that doesn’t heal; unexplained weight loss; blood in stool, urine, or cough; a persistent cough or hoarseness; or any change that lasts beyond a couple of weeks.

The takeaway

A cancer diagnosis is built from several pieces: history, exam, labs, scans, biopsy, staging, and biomarkers, and each one answers a different question. Understanding what each test is for helps you ask better questions and avoid delays. If you’ve had a worrying finding or a recent diagnosis and want a clear, coordinated starting point, book a consultation with Dr Aditya Sarin. 

References

Frequently Asked Questions

How is cancer diagnosed?

Through a combination of history, physical exam, lab tests, imaging, and almost always a biopsy. No single test diagnoses cancer; a biopsy confirms it.

Can a CT scan or PET-CT diagnose cancer on its own?

No. Scans can show a mass, its size, and its location, but they can’t confirm cancer. A biopsy is needed for that.

Are CT scans safe?

CT scans use more radiation than X-rays, and added exposure can slightly raise lifetime cancer risk. For people who need them, the benefit generally outweighs the small risk. Tell your doctor if you’re pregnant or have had a reaction to contrast dye.

How much does a PET-CT scan cost in India?

Many centres charge roughly ₹10,000 to ₹25,000, while some hospital networks charge more. Ask for a written price and check whether your insurance or state scheme covers it.

Do tumour marker blood tests detect cancer?

Not reliably on their own. Many markers are also produced by normal cells, so results must be read alongside scans and biopsy, and they aren’t generally used to screen healthy people.

Is there free cancer screening in India?

Yes. People aged 30 and above can be screened for oral, breast, and cervical cancer at Ayushman Arogya Mandirs and public health facilities under the national NCD programme.

Dr. Aditya Sarin — Medical Oncologist, Sir Ganga Ram Hospital, Delhi
Medically reviewed & written by

Dr. Aditya Sarin

Consultant, Medical Oncology · Sir Ganga Ram Hospital, New Delhi

MD (General Medicine) · DrNB (Medical Oncology) · ESMO (European) Board Certified

Dr. Aditya Sarin is a medical oncologist who combines precision molecular profiling with evidence-based, compassionate cancer care. Named Young Medical Oncologist of the Year, he treats the full spectrum of solid and blood cancers through a multidisciplinary tumor-board approach at Sir Ganga Ram Hospital.

Breast Cancer Lung Cancer GI Cancers Head & Neck Gynecologic Cancers Immunotherapy Targeted Therapy Precision / Molecular Oncology Leukemia · Lymphoma · Myeloma

Breast Cancer Treatment in India: Options and Costs

Summary

Breast cancer treatment centres on three factors: the stage, the tumour's receptor status (ER, PR, and HER2), and your overall health. Most people receive a combination of surgery, radiation, and drug treatment, which can include chemotherapy, hormone therapy, and targeted therapy. HER2-positive breast cancer, which makes up roughly 15 to 20% of cases, responds well to HER2-targeted drugs like trastuzumab, and cheaper Indian biosimilars have made these far more accessible.

Costs in India range from a few lakh rupees for early-stage disease to well over ₹10 lakh for locally advanced cases. The earlier it's caught, the simpler and cheaper treatment usually is.

Breast Cancer Treatment in India: Options, Costs and What to Expect

How breast cancer is treated, what HER2-positive disease means, and what each step costs

This page is for informational purposes only and does not replace medical advice. Please consult Dr Aditya Sarin or a qualified oncologist about your specific diagnosis and plan. Costs vary by hospital and change often, so confirm figures with your care team. As of 2026, this reflects current clinical guidance.

A breast cancer diagnosis comes with a lot of decisions at once: surgery or not, chemo or not, what the receptor results mean, and what it will all cost. This guide walks through the standard options, how doctors choose between them, and what to expect in India, so you can go into those conversations better prepared.

Breast cancer in India: Why timing matters

Breast cancer is the most common cancer among women in India. According to GLOBOCAN 2022 figures cited in JCO Global Oncology, India recorded about 192,020 new cases and 98,337 deaths that year. The same review points to late-stage presentation and limited access to diagnostics as ongoing problems.

Age and stage matter. A review in the World Journal of Clinical Oncology notes that a higher proportion of breast cancer occurs at a younger age in Indian women than in the West, and links poorer survival partly to late presentation and delayed treatment. Hospital series from India have reported a notably higher share of stage IV disease at diagnosis than in the US. The practical lesson: a new lump, nipple discharge, skin dimpling, or persistent armpit swelling deserves a prompt clinical examination, not a wait-and-see approach.

How is breast cancer treatment decided?

Stage and grade

Stage describes the tumour’s size and whether it has spread to lymph nodes or other organs. Grade describes how abnormal the cells look.

Receptor status: The three main subtypes

The biopsy is tested for estrogen receptor (ER), progesterone receptor (PR), and HER2. These results sort breast cancers into groups that behave and respond differently:

  • Hormone receptor-positive: fuelled by estrogen or progesterone, so hormone-blocking treatment works
  • HER2-positive: carries extra HER2 protein, so HER2-targeted drugs work
  • Triple-negative: lacks all three, so chemotherapy (and sometimes immunotherapy) carries more of the load

Cancer Australia notes that chemotherapy is more likely when the cancer has no hormone receptors, and that HER2 status can change which chemotherapy is used and when.

Breast cancer surgery in India

Surgery is usually part of early-stage treatment. Cancer Australia describes the two main approaches as breast-conserving surgery and mastectomy, with reconstruction possible after mastectomy.

Lumpectomy vs mastectomy

A lumpectomy removes the tumour and a margin of surrounding tissue. A mastectomy removes the whole breast. For early-stage cancer, lumpectomy followed by radiation is generally considered as effective as mastectomy at preventing recurrence, according to Care Hospitals. The right choice depends on tumour size, location, how many areas are involved, genetic risk, and your preference. Neither is automatically “safer.”

Lymph node surgery

Surgeons usually check the lymph nodes under the arm, often with a sentinel node biopsy that identifies the first nodes cancer would reach. The results help stage the cancer and guide whether more treatment is needed.

Breast reconstruction

Reconstruction can be done at the same time as a mastectomy or later, using implants or your own tissue. It’s optional, and it’s worth raising early, because the plan for surgery and radiation affects the options.

Radiation therapy

Radiation is almost always recommended after breast-conserving surgery, and sometimes after mastectomy, to destroy remaining cancer cells. It’s delivered by a radiation oncologist as a course over several weeks. If you’d like a clearer picture of that role, see our guide to radiation vs medical oncologists.

Breast cancer chemotherapy

Chemotherapy kills fast-dividing cells throughout the body, and it’s used when there’s a meaningful risk that cancer cells have spread beyond the breast and armpit.

Before or after surgery

CancerCare explains that chemotherapy can be given before surgery (neoadjuvant) to shrink the tumour so surgery can be less extensive, or after surgery (adjuvant) to destroy remaining cells. It’s particularly important in triple-negative disease. Side effects are real but manageable, and our chemotherapy side effects guide covers nausea, fatigue, hair loss, and when to call your team.

Hormone therapy

For ER- or PR-positive cancers, hormone therapy reduces estrogen’s effect on cancer cells. Tamoxifen is the best-known example, an estrogen-blocking treatment. The choice of drug depends on hormone receptors and whether you’ve reached menopause. You usually take it as a daily tablet for several years, so it’s worth discussing long-term side effects and how to stay on schedule upfront.

Targeted therapy for HER2-positive breast cancer

HER2-positive breast cancer used to carry a worse outlook. Targeted drugs changed that. Targeted therapy for breast cancer works by attacking cells with high levels of the HER2 protein, and it’s usually combined with chemotherapy.

The main HER2-targeted drugs

According to CancerCare:

  • Trastuzumab (Herceptin) is a standard treatment, typically taken for one year in early-stage disease
  • Pertuzumab (Perjeta) is added to trastuzumab and chemotherapy before surgery in some patients
  • Ado-trastuzumab emtansine (T-DM1, Kadcyla) joins trastuzumab to a chemotherapy drug
  • Neratinib (Nerlynx) can be given after a year of trastuzumab to further reduce recurrence in selected patients

Not everyone qualifies. HER2 status is determined by your pathology report, and these drugs work only on HER2-positive tumours.

Biosimilars have changed the cost picture in India

Trastuzumab biosimilars are among the biggest affordability wins in Indian oncology. A real-world analysis presented at ISPOR Europe 2025 found the originator at ₹55,000 to ₹75,000 per 440 mg vial in private pharmacies, versus ₹18,000 to ₹30,000 for biosimilars, a 50 to 70% reduction. Pertuzumab is catching up: Alkem launched a biosimilar in India in September 2025, according to BioSpectrum, which noted that cost had kept pertuzumab out of reach for many patients.

Triple-negative breast cancer and immunotherapy

Triple-negative breast cancer lacks the targets for hormone and HER2 therapy, so chemotherapy is the mainstay. For some high-risk early-stage cases, the US FDA approved pembrolizumab alongside chemotherapy in 2021. Whether it applies to you, and whether it’s accessible, is a conversation for your oncologist. 

Breast cancer treatment cost in India

Costs vary by stage, subtype, hospital, and drugs, so treat these as rough ranges, not quotes. Published figures differ between sources.

Cost by stage

Stage

Typical treatment

Indicative total cost

Stage I

Lumpectomy or localised surgery, often with radiation

About ₹2 to 4 lakh

Stage II

Surgery, chemotherapy, radiation

About ₹5 to 8 lakh

Stage III

More extensive surgery, multiple chemotherapy cycles, targeted therapy

About ₹8 to 15 lakh

Stage IV

Depends on drugs and duration of treatment

Varies widely

Source: HCG Oncology, which also puts breast cancer surgery alone at roughly ₹1.5 to 5 lakh depending on whether it’s a lumpectomy, mastectomy, or includes reconstruction.

What HER2 treatment adds

A full course of trastuzumab runs about 18 cycles. When biosimilars launched in 2019, Intas estimated that this dropped from more than ₹10 lakh to under ₹4 lakh (GaBI Online). Prices have fallen further since, but a total plan with pertuzumab or T-DM1 costs significantly more.

Ways to pay

Ayushman Bharat PM-JAY covers cancer treatment for eligible families up to ₹5 lakh a year, and Delhi joined the scheme in 2025, as covered in our guide to cancer treatment in India. Ask whether your specific drugs are covered, and check private insurance sub-limits too.

What to expect during treatment

A typical early-stage path looks something like this, though yours will be tailored:

  • Diagnosis and staging: biopsy, receptor tests, and imaging
  • Surgery (or chemotherapy first, if the plan starts with shrinking the tumour)
  • Chemotherapy and/or targeted therapy, usually over several months
  • Radiation, often after surgery
  • Hormone therapy, if hormone receptor-positive, for years
  • Follow-up, with regular check-ups and imaging

Treatment is a long road, and it’s normal to need support along the way. Ask your team early about nutrition, fertility preservation (if you’re younger), and emotional support.

The takeaway

Breast cancer is highly treatable, particularly when found early, and the right plan depends on your stage and receptor status rather than on one-size-fits-all steps. If you’ve been diagnosed, a medical oncologist can help coordinate surgery, systemic therapy, and radiation into one plan. To discuss your own case, book a consultation with Dr Aditya Sarin.

References

Frequently Asked Questions

What is HER2-positive breast cancer?

It’s breast cancer with extra HER2 protein on the surface of its cells, which can make it grow faster. It makes up roughly 15 to 20% of breast cancers and responds well to HER2-targeted drugs like trastuzumab.

Do I need a mastectomy or is a lumpectomy enough?

For many early-stage cancers, a lumpectomy followed by radiation works as well as mastectomy. The right choice depends on tumour size and location, genetics, and your preferences.

Will I need chemotherapy for breast cancer?

Not always. It depends on stage, receptor status, and the risk of spread. It’s more likely when the cancer is triple-negative or lymph nodes are involved.

How much does breast cancer treatment cost in India?

Early-stage treatment often runs from about ₹2 to 4 lakh, while locally advanced disease can cost ₹8 to 15 lakh or more. Targeted drugs and hospital type affect the total.

Are cheaper trastuzumab biosimilars as good as the original?

Biosimilars are approved in India for use as alternatives, and studies describe them as significantly improving access. Ask your oncologist which brand is appropriate for you.

Can I keep my breast during treatment?

Often yes, if the tumour is small enough relative to the breast, or if chemotherapy shrinks it first. Your surgeon will discuss this based on your scans and biopsy.

Dr. Aditya Sarin — Medical Oncologist, Sir Ganga Ram Hospital, Delhi
Medically reviewed & written by

Dr. Aditya Sarin

Consultant, Medical Oncology · Sir Ganga Ram Hospital, New Delhi

MD (General Medicine) · DrNB (Medical Oncology) · ESMO (European) Board Certified

Dr. Aditya Sarin is a medical oncologist who combines precision molecular profiling with evidence-based, compassionate cancer care. Named Young Medical Oncologist of the Year, he treats the full spectrum of solid and blood cancers through a multidisciplinary tumor-board approach at Sir Ganga Ram Hospital.

Breast Cancer Lung Cancer GI Cancers Head & Neck Gynecologic Cancers Immunotherapy Targeted Therapy Precision / Molecular Oncology Leukemia · Lymphoma · Myeloma